FindTrial
Sign In

Ablation therapy

PROCEDURE7 trials

Sponsors

Ishihara Ryu, Mayo Clinic, Institut Paoli-Calmettes, M.D. Anderson Cancer Center, Shanghai Zhongshan Hospital

Conditions

AblationArrhythmiaAtrial FibrillationHepatitis CHepatocellular CarcinomaHyperthyroidism/ThyrotoxicosisMalignant Liver NeoplasmNonresectable Bile Duct Cancer

Phase 2

Prospective Evaluation of the Ablation Therapy With Bipolar Radio Frequency for Nonresectable Bile Duct Cancer
CompletedNCT03679338
Institut Paoli-CalmettesNonresectable Bile Duct Cancer
Start: 2018-03-22End: 2022-03-11Updated: 2023-06-23
Software-Aided Imaging (Morfeus) for Confirming Tumor Coverage With Ablation in Patients With Liver Tumors, the COVER-ALL Study
Active, not recruitingNCT04083378
M.D. Anderson Cancer CenterMalignant Liver Neoplasm
Start: 2020-01-10End: 2026-10-31Updated: 2026-03-23
A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules
RecruitingNCT04905056
Shanghai Zhongshan HospitalProgression
Start: 2021-01-01End: 2028-12-31Target: 120Updated: 2021-05-27
Endoscopic ablation therapy for superficial esophageal squamous cell carcinoma
RecruitingJPRN-jRCT1052220106
Ishihara Ryusuperficial esophageal squamous cell carcinoma Esophageal Squamous Cell Carcinoma
Start: 2022-10-06Target: 27Updated: 2025-07-18

Unknown Phase

Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial
CompletedNCT00578617
Mayo ClinicArrhythmia, Atrial Fibrillation
Start: 2006-09-30End: 2010-06-30Updated: 2013-01-04
Ablation of Hepatocellular Carcinoma: a Nationwide Study
CompletedNCT05498779
Rigshospitalet, DenmarkAblation, Hepatitis C, Hepatocellular Carcinoma
Start: 2022-06-01End: 2023-09-01Updated: 2023-11-28
Clinical Study of Ultrasound-guided Radiofrequency Ablation in the Treatment of Refractory Hyperthyroidism
Active, not recruitingNCT06305871
Zhang BoHyperthyroidism/Thyrotoxicosis
Start: 2023-08-01End: 2025-07-31Target: 20Updated: 2024-03-12

Related Papers

Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomised phase 2 trial.
2025-03-1322 citations
Study Protocol COVER-ALL: Clinical Impact of a Volumetric Image Method for Confirming Tumour Coverage with Ablation on Patients with Malignant Liver Lesions.
2022-09-0418 citations